David R Coghill

Summary

Affiliation: University of Dundee
Country: UK

Publications

  1. ncbi request reprint Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder
    Sinead M Rhodes
    Division of Pathology and Neuroscience, University of Dundee, UK
    Psychol Med 35:1109-20. 2005
  2. doi request reprint Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee
    David Coghill
    Division of Medical Sciences, Centre for Neuroscience, Maternal and Child Health Sciences 2, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK
    Eur Child Adolesc Psychiatry 20:75-81. 2011
  3. doi request reprint Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis
    David R Coghill
    Division of Neuroscience, Medical Research Institute, University of Dundee, Ninewells Hospital Electronic address
    Biol Psychiatry 76:603-15. 2014
  4. pmc Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD
    Donna C McCann
    Developmental Brain and Behaviour Lab, Psychology, University of Southampton, Southampton SO17 1BJ, UK
    Trials 15:142. 2014
  5. pmc An inventory of European data sources for the long-term safety evaluation of methylphenidate
    Macey L Murray
    Centre for Paediatric Pharmacy Research, University College London School of Pharmacy, London, UK
    Eur Child Adolesc Psychiatry 22:605-18. 2013
  6. pmc A systematic review of the safety of lisdexamfetamine dimesylate
    David R Coghill
    Division of Neuroscience, University of Dundee, Dundee, UK
    CNS Drugs 28:497-511. 2014
  7. doi request reprint Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design
    David R Coghill
    University of Dundee, UK Electronic address
    J Am Acad Child Adolesc Psychiatry 53:647-657.e1. 2014
  8. pmc Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    David R Coghill
    Division of Neuroscience, Ninewells Hospital, University of Dundee, Dundee, UK
    Eur Child Adolesc Psychiatry 23:61-8. 2014
  9. pmc Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    David Coghill
    Division of Neuroscience, Medical Research Institute, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
    BMC Psychiatry 13:237. 2013
  10. doi request reprint European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    David Coghill
    Division of Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK Electronic address
    Eur Neuropsychopharmacol 23:1208-18. 2013

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder
    Sinead M Rhodes
    Division of Pathology and Neuroscience, University of Dundee, UK
    Psychol Med 35:1109-20. 2005
    ....
  2. doi request reprint Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee
    David Coghill
    Division of Medical Sciences, Centre for Neuroscience, Maternal and Child Health Sciences 2, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK
    Eur Child Adolesc Psychiatry 20:75-81. 2011
    ....
  3. doi request reprint Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis
    David R Coghill
    Division of Neuroscience, Medical Research Institute, University of Dundee, Ninewells Hospital Electronic address
    Biol Psychiatry 76:603-15. 2014
    ..Methylphenidate (MPH) is an effective treatment for ADHD symptoms, but its impact on cognition is less clearly understood...
  4. pmc Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD
    Donna C McCann
    Developmental Brain and Behaviour Lab, Psychology, University of Southampton, Southampton SO17 1BJ, UK
    Trials 15:142. 2014
    ..This trial will compare the adapted-NFPP with a generic parenting group-based programme, Incredible Years (IY), which has been recommended for children with preschool-type ADHD symptoms...
  5. pmc An inventory of European data sources for the long-term safety evaluation of methylphenidate
    Macey L Murray
    Centre for Paediatric Pharmacy Research, University College London School of Pharmacy, London, UK
    Eur Child Adolesc Psychiatry 22:605-18. 2013
    ..Many European healthcare databases can be used for multinational long-term safety studies of MPH. Methodological research is underway to investigate the feasibility of their pooling and analysis...
  6. pmc A systematic review of the safety of lisdexamfetamine dimesylate
    David R Coghill
    Division of Neuroscience, University of Dundee, Dundee, UK
    CNS Drugs 28:497-511. 2014
    ..Here we review the safety and tolerability profile of lisdexamfetamine dimesylate (LDX), the first long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD)...
  7. doi request reprint Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design
    David R Coghill
    University of Dundee, UK Electronic address
    J Am Acad Child Adolesc Psychiatry 53:647-657.e1. 2014
    ....
  8. pmc Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
    David R Coghill
    Division of Neuroscience, Ninewells Hospital, University of Dundee, Dundee, UK
    Eur Child Adolesc Psychiatry 23:61-8. 2014
    ....
  9. pmc Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
    David Coghill
    Division of Neuroscience, Medical Research Institute, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
    BMC Psychiatry 13:237. 2013
    ..The objective of this systematic review was to compare the evidence available from head-to-head studies of long-acting MPH formulations and provide information that can guide treatment selection...
  10. doi request reprint European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    David Coghill
    Division of Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK Electronic address
    Eur Neuropsychopharmacol 23:1208-18. 2013
    ..Mean changes in vital signs were modest and consistent with the known profile of LDX. LDX was effective and generally well tolerated in children and adolescents with ADHD...
  11. pmc Occupational issues of adults with ADHD
    Marios Adamou
    South West Yorkshire NHS Partnership Foundation Trust Manygates Clinic, Portobello Road, WF1 5PN, Wakefield, UK
    BMC Psychiatry 13:59. 2013
    ..ADHD is a common neurodevelopmental disorder that persists into adulthood. Its symptoms cause impairments in a number of social domains, one of which is employment. We wish to produce a consensus statement on how ADHD affects employment...
  12. pmc The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
    Marina Danckaerts
    Department of Child and Adolescent Psychiatry, University Hospitals Leuven, Leuven, Belgium
    Eur Child Adolesc Psychiatry 19:83-105. 2010
    ..In conclusion, ADHD seriously compromises QoL especially when seen from a parents' perspective. QoL outcomes should be included as a matter of course in future treatment studies...
  13. pmc Avoiding the 'twilight zone': recommendations for the transition of services from adolescence to adulthood for young people with ADHD
    Susan Young
    Department of Forensic and Neurodevelopmental Sciences, King s College London, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK
    BMC Psychiatry 11:174. 2011
    ..We conclude with recommendations on how to develop transition services for young people with ADHD...
  14. doi request reprint Pragmatic measures in paediatric psychopharmacology--are we getting it right?
    David Coghill
    Centre for Neuroscience, Division of Medical Sciences, University of Dundee, Centre for Child Health, 19 Dudhope Terrace, Dundee DD36HH, UK
    Eur Neuropsychopharmacol 21:571-83. 2011
    ..In addition to reporting the basic outcomes from these studies researchers should use these data to improve the measurement models and refine both the measures and the trial designs...
  15. doi request reprint The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review
    David Coghill
    Centre for Neuroscience, Division of Medical Sciences, University of Dundee, Centre for Child Health, Dundee, UK
    CNS Drugs 24:843-66. 2010
    ..The lack of systematic studies of the impact on QOL of psychological therapies, either on their own or in multimodal combinations with medication, is a serious omission that should be urgently addressed...
  16. ncbi request reprint Osmotic, controlled-release methylphenidate for the treatment of ADHD
    David Coghill
    Department of Pathology and Neuroscience, Ninewells Hospital and Medical School, Ninewells Avenue, Dundee, DD1 9SY, UK
    Expert Opin Pharmacother 7:2119-38. 2006
    ..There have been a smaller number of trials comparing OROS MPH with non-stimulant treatments, such as atomoxetine...
  17. ncbi request reprint The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder
    David R Coghill
    Section of Psychiatry and Behavioral Sciences, Division of Pathology and Neuroscience, University of Dundee, Ninewells Medical School, Dundee, United Kingdom
    Biol Psychiatry 62:954-62. 2007
    ..The assumed relationships between these neuropsychological effects and clinical efficacy have not been substantiated. We therefore investigated the effects of chronic MPH administration on neuropsychological functioning...
  18. doi request reprint The genetics of attention-deficit/hyperactivity disorder
    David Coghill
    Centre for Neuroscience, Division of Medical Sciences, University of Dundee, Centre for Child Health, 19 Dudhope Terrace, Dundee, DD3 6HH, UK
    Expert Rev Neurother 9:1547-65. 2009
    ..Gene-environment interactions, which are as yet relatively understudied, are likely to be of importance in fully understanding the role of genes in ADHD and will be discussed...
  19. ncbi request reprint Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains
    Sinead M Rhodes
    Section of Psychiatry and Behavioural Sciences, Division of Pathology and Neuroscience, University of Dundee, Ninewells Medical School, Dundee, UK
    J Child Psychol Psychiatry 47:1184-94. 2006
    ..The present study was designed to investigate the acute effects of the psychostimulant drug, methylphenidate (MPH), on neuropsychological performance in stimulant naïve boys with ADHD...
  20. doi request reprint Neuropsychological functioning in depressed adolescent girls
    Keith Matthews
    Section of Psychiatry and Behavioural Sciences, Division of Pathology and Neuroscience, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
    J Affect Disord 111:113-8. 2008
    ..We describe the neuropsychological functioning of a referred sample of medication-naïve adolescent girls meeting criteria for a diagnosis of Depressive Episode (ICD-10)...
  21. ncbi request reprint Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management
    Johnny Graham
    Child and Adolescent Psychiatry, University of Dundee, Section of Psychiatry, Division of Pathology and Neuroscience, Ninewells Hospital, Dundee, Scotland
    CNS Drugs 22:213-37. 2008
    ..For example, the latter shares the stimulant group's potential for changing cardiovascular parameters, but may not cause insomnia...
  22. ncbi request reprint Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder
    Sinead M Rhodes
    Department of Psychiatry, Ninewells Medical School, University of Dundee, Dundee, UK
    Psychopharmacology (Berl) 175:319-30. 2004
    ..Further, the impact of methylphenidate (MPH) on key neuropsychological processes in AD-HKD remains poorly understood...
  23. ncbi request reprint Which factors impact on clinician-rated impairment in children with ADHD?
    David Coghill
    Section of Psychiatry Division of Pathology and Neuroscience, University of Dundee, Dundee, Scotland, UK
    Eur Child Adolesc Psychiatry 15:I30-7. 2006
    ....
  24. doi request reprint A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder
    Sinead M Rhodes
    Department of Psychology, University of Strathclyde, Glasgow, UK
    J Child Psychol Psychiatry 53:128-37. 2012
    ..We conducted a comprehensive and systematic assessment of memory functioning in drug-naïve boys with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD)...
  25. doi request reprint Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder
    Mark E Bangs
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Pediatrics 121:e314-20. 2008
    ..In this study we examined the effectiveness of atomoxetine for the treatment of oppositional defiant disorder comorbid with attention-deficit/hyperactivity disorder...